30510400|t|Notch inhibitor can attenuate apparent diffusion coefficient and improve neurological function through downregulating NOX2-ROS in severe traumatic brain injury.
30510400|a|INTRODUCTION: Secondary brain injury is a major factor that affects the prognosis and outcome of traumatic brain injury (TBI) patients. Secondary brain edema is considered to be an initiating factor in secondary brain injury after TBI. A previous study has indicated that Notch signaling activation contributes to neuron death in mice affected by stroke; however, its role in neuronal oxidation stress for brain edema after TBI is not well established. Apparent diffusion coefficient (ADC) values can represent the brain edema after TBI. METHODS: We established a rat model of acute craniocerebral injury, using functional MRI to evaluate the ADC and cerebral blood flow values. The present study was designed to determine the effect of Notch inhibitor DAPT upon oxidation stress for brain edema after TBI. Rats were randomly distributed into five groups, control group, severe TBI group, severe TBI + vehicle group, severe TBI + DAPT group, and severe TBI + DPI group. All rats were sacrificed at 24 hours after TBI. RESULTS: Our data indicated that Notch signaling inhibitor DAPT significantly reduced the ADC values and improved the neurological function after TBI. In addition, DAPT decreased NOX2 levels and the ROS levels. Furthermore, DPI can decrease NOX2 levels and ROS levels. CONCLUSION: This study indicated that DAPT Notch signal inhibitors can inhibit NOX2-ROS generation, reduce the ADC values, relieve cerebral edema, and improve nerve function.
30510400	0	5	Notch	Gene	25496
30510400	118	122	NOX2	Gene	66021
30510400	123	126	ROS	Chemical	-
30510400	137	159	traumatic brain injury	Disease	MESH:D000070642
30510400	185	197	brain injury	Disease	MESH:D001930
30510400	258	280	traumatic brain injury	Disease	MESH:D000070642
30510400	282	285	TBI	Disease	MESH:D000070642
30510400	287	295	patients	Species	9606
30510400	307	318	brain edema	Disease	MESH:D001929
30510400	373	385	brain injury	Disease	MESH:D001930
30510400	392	395	TBI	Disease	MESH:D000070642
30510400	433	438	Notch	Gene	25496
30510400	491	495	mice	Species	10090
30510400	508	514	stroke	Disease	MESH:D020521
30510400	567	578	brain edema	Disease	MESH:D001929
30510400	585	588	TBI	Disease	MESH:D000070642
30510400	676	687	brain edema	Disease	MESH:D001929
30510400	694	697	TBI	Disease	MESH:D000070642
30510400	725	728	rat	Species	10116
30510400	744	765	craniocerebral injury	Disease	MESH:D006259
30510400	898	903	Notch	Gene	25496
30510400	914	918	DAPT	Chemical	-
30510400	945	956	brain edema	Disease	MESH:D001929
30510400	963	966	TBI	Disease	MESH:D000070642
30510400	968	972	Rats	Species	10116
30510400	1039	1042	TBI	Disease	MESH:D000070642
30510400	1057	1060	TBI	Disease	MESH:D000070642
30510400	1085	1088	TBI	Disease	MESH:D000070642
30510400	1091	1095	DAPT	Chemical	-
30510400	1114	1117	TBI	Disease	MESH:D000070642
30510400	1120	1123	DPI	Chemical	-
30510400	1135	1139	rats	Species	10116
30510400	1174	1177	TBI	Disease	MESH:D000070642
30510400	1212	1217	Notch	Gene	25496
30510400	1238	1242	DAPT	Chemical	-
30510400	1325	1328	TBI	Disease	MESH:D000070642
30510400	1343	1347	DAPT	Chemical	-
30510400	1358	1362	NOX2	Gene	66021
30510400	1378	1381	ROS	Chemical	-
30510400	1403	1406	DPI	Chemical	-
30510400	1420	1424	NOX2	Gene	66021
30510400	1436	1439	ROS	Chemical	-
30510400	1486	1490	DAPT	Chemical	-
30510400	1491	1496	Notch	Gene	25496
30510400	1527	1531	NOX2	Gene	66021
30510400	1532	1535	ROS	Chemical	-
30510400	1579	1593	cerebral edema	Disease	MESH:D001929
30510400	Negative_Correlation	25496	66021
30510400	Association	MESH:D000070642	25496
30510400	Association	MESH:D001929	25496
30510400	Association	MESH:D020521	25496

